New strategies for targeting transactivation domains: insights from the androgen receptor
Year: 2022
Type: dissertation
Abstract: Transcription factors are, in theory, ideal targets for developing new therapies, as they drive the expression of genes, oftentimes those that lead to pathologies. However, these proteins typically contain large intrinsically disordered regions that are not amenable to classical structure-based drug discovery. Advances in understanding the rules governing the function of transcription factors can open new avenues to diseases that were previously considered incurable. In this work, we take advantage of recent developments, specifically those in the field of biomolecular condensation and identification of protein binders of the androgen receptor to further the different stages of drug development towards new strategies to fight castration resistant prostate cancer. To this end, we developed a new in vitro condensation assay that allowed us to identify small molecules targeting the activation domain of the androgen receptor. We also explore the features of the interaction between the androgen receptor and general transcription factor IIF and describe two attempts to disrupt this interaction. Taken together, these studies provide new insights and methods to better understand the function and druggability of transactivation domains, using the androgen receptor as an example.
Author: Biesaga, Mateusz
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7110501966
